Stoke Therapeutics, Inc. announced the appointment of Jennifer Burstein to its board of directors. Ms. Burstein will join the audit committee and serve as its chair. Ms. Burstein most recently served as senior vice president of finance and principal financial officer at Loxo Oncology, Inc., until its acquisition by Eli Lilly and Company in January 2019.